Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses RCKT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named RCKT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Christopher Stevens | $242,308 | $125,000 | $1,250,000 | $1,700,998 | $236,250 | $0 | $911 | $3,555,467 |
| Chief Operating Officer | ||||||||
| Gaurav Shah | 671,076 | 0 | 806,751 | 1,613,377 | 403,048 | 0 | 15,988 | 3,510,241 |
| Chief Executive Officer and Director | ||||||||
| Martin Wilson | 488,279 | 0 | 1,737,737 | 892,676 | 265,868 | 0 | 13,320 | 3,397,880 |
| General Counsel and Chief Corporate Officer, Senior Vice President, Interim Principal Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Christopher Stevens | $3,555,467 | — | — | — |
| Gaurav Shah | 3,510,241 | 6,841,407 | — | −3,331,166 |
| Martin Wilson | 3,397,880 | 2,113,954 | — | +1,283,926 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Sarbani Chaudhuri | See Remarks | 2026-05-07 | D | 17,650 | $4 | $67,741 | Common | Form 4 ↗ |
| Martin Wilson | General Counsel | 2026-05-13 | D | 3,361 | 4 | 12,120 | Common | Form 4 ↗ |
| Gaurav Shah | CEO | 2026-05-13 | D | 2,728 | 4 | 9,837 | Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-13 | D | 855 | 4 | 3,083 | Common | Form 4 ↗ |
| Martin Wilson | General Counsel | 2026-05-19 | D | 662 | 3 | 1,995 | Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-19 | D | 384 | 3 | 1,157 | Common | Form 4 ↗ |
| Gaurav Shah | CEO | 2026-05-19 | D | 2,409 | 3 | 7,261 | Common | Form 4 ↗ |
| Gaurav Shah | CEO | 2026-05-21 | D | 76,490 | 2 | 129,345 | Derivative, Class A Common | Form 4 ↗ |
| Gaurav Shah | CEO | 2026-05-21 | D | 55,684 | 3 | 171,841 | Common, open-market sale | Form 4 ↗ |
| Gaurav Shah | CEO | 2026-05-21 | A | 76,490 | 2 | 129,345 | Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | A | 15,002 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | A | 24,899 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 10,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 18,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 49,798 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | A | 9,091 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 27,003 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 24,545 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 10,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 2,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | A | 51,509 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | A | 16,061 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 18,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 10,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Militello | See Remarks | 2026-05-26 | D | 28,910 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Peter Fong | Director | 2026-06-18 | A | 64,860 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Roderick Wong | Director | 2026-06-18 | A | 27,832 | 0 | 0 | RSU | Form 4 ↗ |
| David Southwell | Director | 2026-06-18 | A | 64,860 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carsten Boess | Director | 2026-06-18 | A | 22,862 | 0 | 0 | RSU | Form 4 ↗ |
| Fady Malik | Director | 2026-06-18 | A | 22,862 | 0 | 0 | RSU | Form 4 ↗ |
| Mikael Dolsten | Director | 2026-06-18 | A | 22,862 | 0 | 0 | RSU | Form 4 ↗ |
| Mikael Dolsten | Director | 2026-06-18 | A | 64,860 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fady Malik | Director | 2026-06-18 | A | 64,860 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Southwell | Director | 2026-06-18 | A | 22,862 | 0 | 0 | RSU | Form 4 ↗ |
| Carsten Boess | Director | 2026-06-18 | A | 64,860 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Peter Fong | Director | 2026-06-18 | A | 22,862 | 0 | 0 | RSU | Form 4 ↗ |
| Roderick Wong | Director | 2026-06-18 | A | 78,960 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Martin Wilson | OPTION | — | — | — | — | — | $892,676 |
| Christopher Stevens | RSU | — | — | — | — | — | 1,250,000 |
| Christopher Stevens | OPTION | — | — | — | — | — | 1,700,998 |
| Gaurav Shah | OPTION | — | — | — | — | — | 1,613,377 |
| Martin Wilson | RSU | — | — | — | — | — | 1,737,737 |
| Gaurav Shah | RSU | — | — | — | — | — | 806,751 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Martin Wilson | $1,737,737 | $0 | $892,676 | 0.0% |
| Christopher Stevens | 1,250,000 | 0 | 1,700,998 | 0.0% |
| Gaurav Shah | 806,751 | 0 | 1,613,377 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Martin Wilson | Option | 49,091 | 30.01 | — |
| Christopher Stevens | RSU | 407,166 | — | 1,429,153 |
| Gaurav Shah | Option | 81,739 | 30.01 | — |
| Martin Wilson | RSU | 372,586 | — | 1,307,777 |
| Gaurav Shah | Option | 29,021 | 20.04 | — |
| Gaurav Shah | Option | 243,345 | 9.88 | — |
| Christopher Stevens | Option | 554,071 | 3.07 | — |
| Martin Wilson | Option | 7,255 | 20.04 | — |
| Martin Wilson | Option | 134,642 | 9.88 | — |
| Gaurav Shah | RSU | 118,954 | — | 417,529 |
The Company's compensation philosophy has been to target director cash compensation at or below the median and director equity grants in a competitive range of the median as compared to the same peer group the Company uses for executive compensation purposes
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Semler Brossy |
| Clawback policy | True |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-20 | 61,389,376 | 1,671,016 | 223,752 | 97.35% | Passed |
| 2025 | 2025-06-18 | 77,186,221 | 1,437,605 | 515,022 | 98.17% | Passed |
| 2024 | 2024-06-13 | 70,707,935 | 1,134,308 | 109,990 | 98.42% | Passed |
| 2023 | 2023-06-22 | 53,821,833 | 10,527,507 | 18,383 | 83.64% | Passed |
| 2021 | 2021-06-14 | 48,398,773 | 625,867 | 16,212 | 98.72% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-20 | 97.35%a |
| 2025 | 2025-06-18 | 98.17%b |
| 2024 | 2024-06-13 | 98.42%c |
a. Approved under the standard stated in the filing — “Abstentions are not counted as votes cast and therefore will have no effect on the vote on this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions are not counted as votes cast and therefore will have no effect on the vote.”.
c. Approved under the standard stated in the filing — “Abstentions are not counted as votes cast and therefore will have no effect on the vote on this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Piratip PratumsuwanIndependent · Audit · Not standing for re-election | $27,419 | $84,900 | $515,395 | $0 | — | $627,714 |
| Mikael DolstenNot independent | 47,500 | 209,894 | — | 0 | 125,000 | 382,394 |
| Peter FongIndependent · Compensation · Nominating/Governance · Newly elected | 14,319 | 177,066 | — | 0 | — | 191,385 |
| Carsten BoessIndependent · Audit (Chair) · Compensation | 73,125 | 84,900 | — | 0 | — | 158,025 |
| Pedro GranadilloIndependent · Compensation · Departed during FY | — | 154,897 | — | 0 | — | 154,897 |
| Gotham MakkerIndependent · Compensation · Departed during FY | — | 139,900 | — | 0 | — | 139,900 |
| David SouthwellIndependent · Compensation (Chair) · Nominating/Governance (Chair) | 53,750 | 84,900 | — | 0 | — | 138,650 |
| Roderick WongNot independent | — | 134,898 | — | 0 | — | 134,898 |
| Fady MalikIndependent | 47,500 | 84,900 | — | 0 | — | 132,400 |
| Elisabeth BjörkIndependent · Audit · Not standing for re-election | 32,500 | 84,900 | — | 0 | — | 117,400 |
| R. Keith WoodsIndependent · Audit · Commercial · Not standing for re-election · Departed during FY | 32,500 | — | — | 0 | — | 32,500 |
| Naveen YalamanchiIndependent · Departed during FY | 2,581 | — | — | 0 | 0 | 2,581 |
| Gaurav ShahEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | — |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 15,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $331,194 |
| Equity awards (grant-date value) | $1,241,155 |
| All other compensation | $125,000 |
| Total cost of the board | $1,697,349 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Rocket Pharmaceuticals, Inc. | 2025 | Gaurav Shah | $671,076 | $806,751 | $1,613,377 | $403,048 | $3,510,241 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Christopher Stevens | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “2025 Summary Compensation Table” · page 26. As printed: 3,555,467. Filing ↗machine: r4 · c24 · span 358123–358132 |
| 2 | Section 01, Gaurav Shah | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “2025 Summary Compensation Table” · page 26. As printed: 3,510,241. Filing ↗machine: r2 · c24 · span 348766–348775 |
| 3 | Section 01, Martin Wilson | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “2025 Summary Compensation Table” · page 26. As printed: 3,397,880. Filing ↗machine: r5 · c24 · span 362734–362743 |
| 4 | Section 03, Martin Wilson OPTION | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t97 · r5 · c15 · span 361275–361282 |
| 5 | Section 03, Christopher Stevens RSU | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t97 · r4 · c12 · span 355887–355896 |
| 6 | Section 03, Christopher Stevens OPTION | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t97 · r4 · c15 · span 356436–356445 |
| 7 | Section 03, Gaurav Shah OPTION | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t97 · r2 · c15 · span 347078–347087 |
| 8 | Section 03, Martin Wilson RSU | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t97 · r5 · c12 · span 360755–360764 |
| 9 | Section 03, Gaurav Shah RSU | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t97 · r2 · c12 · span 346510–346517 |
| 10 | Section 07, pay ratio | 10-K | 2026-02-26 | 0001193125-26-076551 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 11 | Section 08, Piratip Pratumsuwan | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 627,714. Filing ↗machine: t140 · r9 · c15 · span 698106–698113 |
| 12 | Section 08, Mikael Dolsten | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 382,394. Filing ↗machine: t140 · r4 · c15 · span 683305–683312 |
| 13 | Section 08, Peter Fong | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 191,385. Filing ↗machine: t140 · r5 · c15 · span 686062–686069 |
| 14 | Section 08, Carsten Boess | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 158,025. Filing ↗machine: t140 · r3 · c15 · span 680156–680163 |
| 15 | Section 08, Pedro Granadillo | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 154,897. Filing ↗machine: t140 · r6 · c9 · span 688159–688166 |
| 16 | Section 08, Gotham Makker | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 139,900. Filing ↗machine: t140 · r7 · c9 · span 691134–691141 |
| 17 | Section 08, David Southwell | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 138,650. Filing ↗machine: t140 · r10 · c15 · span 701325–701332 |
| 18 | Section 08, Roderick Wong | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 134,898. Filing ↗machine: t140 · r12 · c9 · span 706262–706269 |
| 19 | Section 08, Fady Malik | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 132,400. Filing ↗machine: t140 · r8 · c15 · span 695344–695351 |
| 20 | Section 08, Elisabeth Björk | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 117,400. Filing ↗machine: t140 · r2 · c15 · span 677364–677371 |
| 21 | Section 08, R. Keith Woods | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 32,500. Filing ↗machine: t140 · r11 · c3 · span 702122–702128 |
| 22 | Section 08, Naveen Yalamanchi | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 2,581. Filing ↗ |
| 23 | Section 08, Gaurav Shah | DEF 14A | 2026-04-06 | 0001140361-26-013335 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 24 | Section 02, Sarbani Chaudhuri 2026-05-07 | Form 4 | 2026-05-11 | 0001140361-26-020649 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Martin Wilson 2026-05-13 | Form 4 | 2026-05-14 | 0001140361-26-021321 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Gaurav Shah 2026-05-13 | Form 4 | 2026-05-14 | 0001140361-26-021315 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, John Militello 2026-05-13 | Form 4 | 2026-05-14 | 0001140361-26-021305 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Martin Wilson 2026-05-19 | Form 4 | 2026-05-21 | 0001140361-26-022446 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, John Militello 2026-05-19 | Form 4 | 2026-05-21 | 0001140361-26-022445 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Gaurav Shah 2026-05-19 | Form 4 | 2026-05-21 | 0001140361-26-022447 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Gaurav Shah 2026-05-21 | Form 4 | 2026-05-26 | 0001140361-26-022894 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Gaurav Shah 2026-05-21 | Form 4 | 2026-05-26 | 0001140361-26-022894 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Gaurav Shah 2026-05-21 | Form 4 | 2026-05-26 | 0001140361-26-022894 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, John Militello 2026-05-26 | Form 4 | 2026-05-28 | 0001140361-26-023153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Peter Fong 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027680 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Roderick Wong 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027681 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, David Southwell 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027677 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Carsten Boess 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027676 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Fady Malik 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027678 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Mikael Dolsten 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027679 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Mikael Dolsten 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027679 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Fady Malik 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027678 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, David Southwell 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027677 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Carsten Boess 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027676 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Peter Fong 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027680 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Roderick Wong 2026-06-18 | Form 4 | 2026-07-06 | 0001140361-26-027681 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 06, 2026 vote | Form 8-K | 2026-05-21 | 0001140361-26-022311 | Item 5.07 · say-on-pay result. As reported: 97.35% (votes for as printed: 61,389,376). Filing ↗ |
| 64 | Section 06, 2025 vote | Form 8-K | 2025-06-18 | 0001140361-25-022996 | Item 5.07 · say-on-pay result. As reported: 98.17% (votes for as printed: 77,186,221). Filing ↗ |
| 65 | Section 06, 2024 vote | Form 8-K | 2024-06-20 | 0001140361-24-030718 | Item 5.07 · say-on-pay result. As reported: 98.42% (votes for as printed: 70,707,935). Filing ↗ |
| 66 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 67 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 68 | Section 09b board cost (computed) | Computed | — | computed | Cash 331,194 + equity 1,241,155 + all other 125,000 = 1,697,349, summed across the director compensation table rows.machine: formula: Σ = 1,697,349 |
| 69 | Rocket Pharmaceuticals, Inc. (subject), Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013335 | CEO total compensation as printed in Rocket Pharmaceuticals, Inc.'s own proxy. As printed: 3,510,241. Filing ↗machine: r2 · c24 · span 348766–348775 |